165 related articles for article (PubMed ID: 12547237)
21. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
[TBL] [Abstract][Full Text] [Related]
22. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R.
Lee PL; Barton JC
Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658
[TBL] [Abstract][Full Text] [Related]
23. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
[TBL] [Abstract][Full Text] [Related]
24. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions.
Chen J; Chloupková M; Gao J; Chapman-Arvedson TL; Enns CA
J Biol Chem; 2007 Dec; 282(51):36862-70. PubMed ID: 17956864
[TBL] [Abstract][Full Text] [Related]
25. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
[TBL] [Abstract][Full Text] [Related]
26. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
[TBL] [Abstract][Full Text] [Related]
27. Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2.
Pelucchi S; Mariani R; Trombini P; Coletti S; Pozzi M; Paolini V; Barisani D; Piperno A
Haematologica; 2009 Feb; 94(2):276-9. PubMed ID: 19144662
[TBL] [Abstract][Full Text] [Related]
28. Heterotypic interactions between transferrin receptor and transferrin receptor 2.
Vogt TM; Blackwell AD; Giannetti AM; Bjorkman PJ; Enns CA
Blood; 2003 Mar; 101(5):2008-14. PubMed ID: 12406888
[TBL] [Abstract][Full Text] [Related]
29. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
30. Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis.
Pellegrino RM; Riondato F; Ferbo L; Boero M; Palmieri A; Osella L; Pollicino P; Miniscalco B; Saglio G; Roetto A
Biomed Res Int; 2017; 2017():2408941. PubMed ID: 28540293
[TBL] [Abstract][Full Text] [Related]
31. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
[TBL] [Abstract][Full Text] [Related]
32. A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.
Bartnikas TB; Wildt SJ; Wineinger AE; Schmitz-Abe K; Markianos K; Cooper DM; Fleming MD
Comp Med; 2013 Apr; 63(2):143-55. PubMed ID: 23582421
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene.
Girelli D; Bozzini C; Roetto A; Alberti F; Daraio F; Colombari R; Olivieri O; Corrocher R; Camaschella C
Gastroenterology; 2002 May; 122(5):1295-302. PubMed ID: 11984516
[TBL] [Abstract][Full Text] [Related]
34. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2.
Kawabata H; Tong X; Kawanami T; Wano Y; Hirose Y; Sugai S; Koeffler HP
Br J Haematol; 2004 Nov; 127(4):464-73. PubMed ID: 15521925
[TBL] [Abstract][Full Text] [Related]
35. The Cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells.
Chen J; Enns CA
J Biol Chem; 2007 Mar; 282(9):6201-9. PubMed ID: 17202145
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload.
Lee PL; Halloran C; West C; Beutler E
Blood Cells Mol Dis; 2001; 27(1):285-9. PubMed ID: 11358389
[TBL] [Abstract][Full Text] [Related]
37. Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis.
Chua AC; Delima RD; Morgan EH; Herbison CE; Tirnitz-Parker JE; Graham RM; Fleming RE; Britton RS; Bacon BR; Olynyk JK; Trinder D
J Hepatol; 2010 Mar; 52(3):425-31. PubMed ID: 20133002
[TBL] [Abstract][Full Text] [Related]
38. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes.
Mendes AI; Ferro A; Martins R; Picanço I; Gomes S; Cerqueira R; Correia M; Nunes AR; Esteves J; Fleming R; Faustino P
Ann Hematol; 2009 Mar; 88(3):229-34. PubMed ID: 18762941
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues.
Roetto A; Di Cunto F; Pellegrino RM; Hirsch E; Azzolino O; Bondi A; Defilippi I; Carturan S; Miniscalco B; Riondato F; Cilloni D; Silengo L; Altruda F; Camaschella C; Saglio G
Blood; 2010 Apr; 115(16):3382-9. PubMed ID: 20179178
[TBL] [Abstract][Full Text] [Related]
40. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
